by Неизвестный
V. Wooten, “Sleep Disorders in Geriatric Patients,” Clinics in Geriatric Medicine, May 1992;8(2):427–39. (back to text)
38
N. G. Bliwise, “Factors Related to Sleep Quality in Healthy Elderly Women,”
Psychology and Aging, March 1992;7(1):83–88. (back to text) 39
S. L. Brown, M. E. Salive, M. Pahor et al., “Occult Caffeine as a Source of
Sleep Problems in an Older Population,” Journal of the American Geriatric Society, August 1995;43(8):860–64. (back to text)
40
J. D. Morrison, “Fatigue as a Presenting Complaint in Family Practice,”
Journal of Family Practice, 1980;10:795. (back to text) 41
G. S. Bonham and P. E. Leaverton, “Coffee Use Habits among Adults,” in I.
S. Scarpa et al. (eds.), Sourcebook on Food and Nutrition, vol 2 (Chicago: Marquis Academic Media, 1980), pp. 334–40. (back to text) 42
“New Hope for Tired People,” U.S. News & World Report, October 31, 1988,71–73. (back to text)
43
D. M. Graham, “Caffeine: Its Identity, Dietary Sources, Intake, and Biological Effects,” Sourcebook on Food and Nutrition (Chicago: Marquis Academic Media, 1980). (back to text)
44
J. S. Lewis and K. Inove, “Effect of Coffee Ingestion on Urinary Thiamine Excretion,” Federal Proceedings, 1981;40:914. (back to text) 45
D. M. Hilker, K. Chan, R. Chen et al., “Antithiamine Effects of Tea,”
Nutrition Reports International, 1971;4:223–27. (back to text) 46
V. Tanphaichitr and B. Wood, “Thiamin,” in Present Knowledge in Nutrition, fifth edition (Washington D.C.: Nutrition Foundation, 1984), pp. 273–84. (back to text)
47
S. L. Vimokesant, S. Kunjara et al. “Beriberi Caused by Antithiamin Factors in Food and Its Prevention,” Annals of the New York Academy of Sciences, 1982;378:123–36. (back to text)
48
L. Massey and T. Berg, “The Effect of Dietary Caffeine on Urinary Excretion of Calcium, Magnesium, Phosphorus, Sodium, Potassium, Chloride and Zinc in Healthy Males,” Nutrition Research, 1985;5:1281–84. (back to text) 49
Neuhauser-Berthold, S. Beine, C. Verwied et al., “Coffee Consumption and Total Body Water Homeostasis as Measured by Fluid Balance and Bioelectrical Impedance Analysis,” Annals of Nutrition and Metabolism, 1997;41(1):29–36.
(back to text)
50
P. Hollingberry and L. Massey, “Effects of Dietary Caffeine and Sucrose on Urinary Calcium Excretion in Adolescents,” Federal Proceedings, 1986;45:375.
(back to text)
51
E. A. Bergman, L. K. Massey, K. J. Wise et al., “Effects of Dietary Caffeine on Renal Handling of Minerals in Adult Women,” Life Sciences, 1990;47(6):557–64. (back to text)
52
K. Van Dyck, S. Tas, H. Robberecht et al., “The Influence of Different Food Components on the In Vitro Availability of Iron, Zinc and Calcium from a Composed Meal,” International Journal of Food Science and Nutrition, November 1996; 47(6):499–506. (back to text)
53
G. Wyshak, R. E. Frisch, T. E. Albright et al., “Non-alcoholic Carbonated Beverage Consumption among Women Former Collegiate Athletes,” Journal of Orthopedic Research, 1989:7:91–99. (back to text)
54
G. Wyshak and R. E. Frisch, “Carbonated Beverages, Dietary Calcium, the Dietary Calcium/Phosphorus Ratio, and Bone Fractures in Girls and Boys,”
Journal of Adolescent Health, 1994;15:210–15. (back to text) 55
N. Kojima, D. Wallace and G. W. Bates, “The Effect of Chemical Agents, Beverages, and Spinach on the In Vitro Solubilization of Iron from Cooked Pinto Beans,” American Journal of Clinical Nutrition, 1981;34:1392–l401. (back to text)
56
T. A. Morck, S. R. Lynch, and J. D. Cook, “Inhibition of Food Iron Absorption by Coffee,” American Journal of Clinical Nutrition, 1983;37:416–20. (back to text)
57
G. B. Gabrielli and G. De Sandre, “Excessive Tea Consumption Can Inhibit the Efficacy of Oral Iron Treatment in Iron-Deficiency Anemia,”
Haematologica, November 1995;80(66):518–20. (back to text) 58
A. C. Bancu, M. Gherman et al., “Regulation of Human Natural Cytotoxicity by IgG. II: Cyclic AMP as a Mediator of Monomeric IgG-induced Inhibition of Natural Killer Cell Activity,” Cellular Immunology, 1988:114(2):246. (back to text)
59
P. T. Paradowski and K. Zeman, “Pentoxifylline,” Postepy Higieny Imedycyny Doswiadczalnej, 1995;49(2):201–20. (back to text)
60
G. Gatti, R. Cavallo, M. L. Sartori et al. “Inhibition by Cortisol of Human Natural Killer (NK) Cell Activity,” Journal of Steroid Biochemistry, January 1987;26(1):49–58. (back to text)
61
H. N. Baybutt and F. Holsboer, “Inhibition of Macrophage Differentiation and
Function by Cortisol,” Endocrinology, July 1990;127(1):476–80. (back to text) 62
O. Khorram, L. Vu, and S. S. Yen, “Activation of Immune Function by Dehydroepiandrosterone (DHEA) in Age-Advanced Men,” Journal of Gerontology, 1997;52A(1):M1-M7. (back to text)
63
J. A. McLachlan, C. D. Serkin, and O. Bakouche, “Dehydroepiandrosterone Modulation of Lippolysaccharide-Stimulated Monocyte Cytotoxicity,” Journal of Immunology. January 1, 1996;156(1):328–35. (back to text) 64
R. J. Reiter, D. X. Tan, B. Poeggeler et al., “Melatonin as a Free Radical Scavenger: Implications for Aging and Age-Related Diseases,” Annals of the New York Academy of Sciences, 1994;719:1–12. (back to text) 65
G. J. Maestroni and A. Conti, “Immuno-derived Opiods as Mediators of the Immuno-enhancing and Anti-stress Action of Melatonin,” Ada Neurologica (Napoli), August 1991;13(4):356–60. (back to text)
66
P. Monteleone, A. Fuschino, G. Nolfe et al., “Tempotal Relationship between Melatonin and Cortisol Responses to Nighttime Physical Stress in Humans,”
Psychoneuroendocrinology, 1992;17(1):81–86. (back to text) 67
G. Heuther, “Melatonin Synthesis in the Gastrointestinal Tract and the Impact of Nutritional Factors on Circulating Melatonin,” Annals of the New York Academy of Sciences, 1994;719:146–58. (back to text)
68
K. P. Wright, Jr., P. Badia, B. L. Myers et al., “Caffeine and Light Effects on Nighttime Melatonin and Temperature Levels in Sleep-deprived Humans,”
Brain Research, January 30, 1997;747(1):78–84. (back to text) 69
S. M. Armstrong and J. R. Redman, “Melatonin: A Chronobiotic with Antiaging Properties?” Medical Hypothesis, April 1991;34(4):300–09. (back to text) 70
W. Pierpaoli and V. Lesnikov, “The Pineal Aging Clock,” Annals of the New York Academy of Sciences, 1994;719:461–71. (back to text) 71
J. E. Blalock, E. M. Smith, and W. J. Meyer, 3rd., “The Pituitaryadrenocortical Axis and the Immune System,” Clinical Endocrinology and Metabolism, 1985;14(4):1021. (back to text)
72
T. L. Pruett and E B. Cerra, “The Physiologic and Metabolic Responses to Stress and Sepsis,” Medical Times, 1985; 113(2):98. (back to text)
Chapter 4
1
W. R. Lovallo, M. Al’Absi, K. Blick et al., “Stress-like Adrenocorticotropin Responses to Caffeine in Young Healthy Men,” Pharmacology; Biochemistry and Behavior, November 1996;55(3):365–69. (back to text) 2
I. Iancu, O. T. Dolberg, and J. Zohar, “Is Caffeine Involved in the Pathogenesis of Combat-stress Reaction?” Military Medicine, April 1996;161(4):230–32.
(back to text)
3
P. Cotton, “Neurophysiology and Philosophy,” Journal of the American Medical Association, 1993;269(12):1485–86. (back to text) 4
D. J. Roca, G. D. Schiller, and D. H. Farb, “Chronic Caffeine or Theophylline Exposure Reduces Gamma-aminobutyric Acid/Benzodiazepine Receptor Site Interactions,” Molecular Pharmacology, May 1988;33(5):481–85. (back to text) 5
L. N. Robins
et al., “Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites,” Archives of General Psychiatry, 1984;41:949–58. (back to text) 6
O. G. Cameron and R. M. Nesse, “Systemic Hormonal and Physiological Correlations in Anxiety Disorders,” Psychoneuroendocrinology, 1988;13(4):287–307. (back to text)
7
F. A. Wiesel, “Positron Emission Tomography in Psychiatry,” Psychiatric Developments, 1989, Spring;7(1):19–47. (back to text)
8
T. Kuboki and H. Suematsu, “Panic Disorder,” Nippon Rinsho, November 1992:50(11):2773–82. (back to text)
9
H. M. van Praag, “Central Monoamine Metabolism in Depression II: Catecholamines and Related Compounds,” Comprehensive Psychiatry, 1980;21(1):44–54. (back to text)
10
J. M. Gorman and M. R. Liebowitz, “Panic and Anxiety Disorders,” in R.
Michels et al. (eds.), Psychiatry, vol. 1 (Philadelphia: J. B. Lippincott, 1985), pp.
1–13. (back to text)
11
R. J. Matthew and W. H. Wilson, “Behavioral and Cerebrovascular Effects of Caffeine in Patients with Anxiety Disorders,” Acta Psychiatrica Scandinavica, July 1990;82(1):17–22. (back to text)
12
M. C. McManamy and P. G. Schube, “Caffeine Intoxication,” New England
Journal of Medicine, 1936;215:616–20. (back to text)
13
P. P. Roy-Byrne and T. W. Uhde, “Exogenous Factors in Panic Disorder: Clinical and Research Implications,” Journal of Clinical Psychiatry, February 1988;49(2):56–61. (back to text)
14
A. Breier, D. S. Charney, and G. R. Heninger, “Agoraphobia with Panic Attacks: Development, Diagnostic Stability, and Course of Illness,” Archives of General Psychiatry, November 1986;43(11):1029–36. (back to text) 15
M. A. Lee, P. Flegel, J. F. Greden et al., “Anxiogenic Effects of Caffeine on Panic and Depressed Patients,” American Journal of Psychiatry, May 1988;145(5):632–35. (back to text)
16
J. P. Boulanger et al., “Increased Sensitivity to Caffeine in Patients with Panic Disorder,” Archives of General Psychiatry, 1984;41:1067–71. (back to text) 17
D. S. Charney, G. R. Heninger, and P. I. Jatlow, “Increased Anxiogenic Effects of Caffeine in Panic Disorders,” Archives of General Psychiatry, March 1985;42(3):233–43. (back to text)
18
D. V. Sheehan, J. C. Ballenger, and G. Jacobsen, “Treatment of Endogenous Anxiety with Phobic, Hysterical and Hypochondriacal Symptoms,” Archives of General Psychiatry, 1980;37:51–59. (back to text)
19
J. D. Lane, R. A. Adcock, R. B. Williams et al., “Caffeine Effects on Cardiovascular and Neuroendocrine Responses to Acute Psychosocial Stress and Their Relationship to Level of Habitual Caffeine Consumption,” Psychosomatic Medicine, MayJune 1990;52(3):320–36. (back to text)
20
D. C. Mackay and J. W. Rollins, “Caffeine and Caffeinism,” Journal of the Royal Navy Medical Service, 1989;75(2):65–67. (back to text) 21
J. R. Hughes, S. T. Higgins, W. K. Bickel et al., “Caffeine SelfAdministration, Withdrawal, and Adverse Effects among Coffee Drinkers,”
Archives of General Psychiatry, July 1991;48(7):611–17. (back to text) 22
J. D. Lane, “Effects of Brief Caffeinated-beverage Deprivation on Mood, Symptoms, and Psychomotor Performance,” Pharmacology, Biochemistry and Behavior, September 1997;58(1):203–08. (back to text)
23
K. Silverman, S. M. Evans, E. C. Strain et al., “Withdrawal Syndrome after the Double-blind Cessation of Caffeine Consumption,” New England Journal of Medicine, October 15, 1992;327(16):1109–14. (back to text)
24
“Pharmacology Update,” Internal Medicine Alert, 1992;14(1):7. (back to text) 25
M. Weissman, “Epidemiology of Depression: Frequency, Risk Groups, and Risk Factors,” in Perspectives on Depressive Disorders: A Review of Recent Research (Washington, D.C.: National Institute of Mental Health, 1986). (back to text)
26
D. A. Regier, R. M. A. Hirschfeld, and F. K. Goodwin, “The NIMH
Depression Awareness, Recognition and Treatment (D/ART) Program: Structure, Aims and Scientific Basis,” American Journal of Psychiatry, 1988;145:1351–57. (back to text)
27
“Caffeine Can Increase Brain Serotonin Levels,” Nutrition Reviews, October 1988;46(10):366–67. (back to text)
28
K. Silverman, S. M. Evans, E. C. Strain et al., “Withdrawal Syndrome after the Double-blind Cessation of Caffeine Consumption,” New England Journal of Medicine, October 15, 1992;327(16): 1109–14. (back to text) 29
R. Caccioatore, A. Helbling, C. Jost et al., “Episodic Headache, Diminished Performance and Depressive Mood” (in German), Schweizerische Rundschau for Medizin Praxis, May 28, 1996;85(22):727–29. (back to text) 30
L. Tondor, N. Rudhause et al., “Course of Seasonal Bipolar Disorder Influenced by Caffeine,” Journal of Affective Disorders, 1991;22:249–51. (back to text)
31
W. H. Frishman, “Beta-adrenergic Blockers,” Medical Clinics of North America, 1988;72:37. (back to text)
32
Physicians’ Desk Reference, 44th edition, 1990. (back to text) 33
Pharmacotherapy, 1987;7:1–15. (back to text)
34
M. A. Lee, P. Flegel, J. F. Greden et al., “Anxiogenic Effects of Caffeine on Panic and Depressed Patients,” American Journal of Psychiatry, May 1988;145(5):632–35. (back to text)
35
T. Kuboki and H. Suematsu, “Panic Disorder,” Nippon Rinsho, May 1994;52(5):1334–38. (back to text)
36
J. F. Mortola, J. H. Liu, J. C. Gillin et al., “Pulsatile Rhythms of Adrenocorticotropin (ACTH) and Cortisol in Women with Endogenous Depression: Evidence for Increased AOTH Pulse Frequency,” Journal of
Clinical Endocrinology and Metabolism, November 1987;65(5):962–68. (back to text)
37
M. Vollrath, W. Wicki, and J. Angst, “The Zurich Study VIII: Insomnia: Association with Depression, Anxiety, Somatic Syndromes, and Course of Insomnia,” European Archives of Psychiatry and Neurological Sciences, 1989;239(2):113–24. (back to text)
38
D. J. Haleem, A. Yasmeen, M. A. Haleem et al., “24 hour Withdrawal Following Repeated Administration of Caffeine Attenuates Brain Serotonin but Not Tryptophan in Rat Brain: Implications for CaffeineInduced Depression,”
Life Sciences, September 29, 1995;57(19):PL285–92. (back to text) 39
T. C. Neylan, “Treatment of Sleep Disturbances in Depressed Patients,”
Journal of Clinical Psychiatry, 1995;56 supplement 2:56–61. (back to text) 40
Anon. “The Impact of Stress on the Recurrence of Bipolar Episodes,” Family Practice Recertification, 1992;14(2):412. (back to text) 41
P J. O’Connor, W. P. Morgan, J. S. Raglin et al., “Mood State and Salivary Cortisol Levels Following Overtraining in Female Swimmers,”
Psychoneuroendocrinology, 1989;14(4):303–10. (back to text) 42
E. Leibenluft, P. L. Fiero, J. J. Bartko et al., “Depressive Symptoms and the Self-reported Use of Alcohol, Caffeine, and Carbohydrates in Normal Volunteers and Four Groups of Psychiatric Outpatients,” American Journal of Psychiatry, February 1993; 150(2) :294–301. (back to text) 43
T. C. Neylan, “Treatment of Sleep Disturbances in Depressed Patients,”
American Journal of Clinical Psychiatry, 1995;56 supplement 2:56–61. (back to text)
44
E. Susman, “Prozac May Rob You of a Good Night’s Sleep,” Medical Tribune News Service; September 16, 1997. (back to text) 45
J. D. Morrison, “Fatigue as a Presenting Complaint in Family Practice,”
Journal of Family Practice, 1980;10:795. (back to text) 46
S. Findlay, “New Hope for Tired People,” U.S. News & World Report, October 31, 1988:71–73. (back to text)
47
W.
S. Terry and B. Phifer, “Caffeine and Memory Performance on the AVLT,” Journal of Clinical Psychology, November 1986;42(6):860–3. (back to text)
48
R. Gilliland and D. Andress, “Ad Lib Caffeine Consumption, Symptoms of Caffeinism, and Academic Performance,” American Journal of Clinical Psychiatry, April 1981;138(4):512–14. (back to text)
49
J. R. Bradley and A. Petree, “Caffeine Consumption, Expectancies of Caffeine-enhanced Performance, and Caffeinism Symptoms among University Students,” Journal of Drug Education, 1990;20(4):319–28. (back to text) 50
C. H. Ashton and F. Kamali, “Personality, Lifestyles, Alcohol and Drug Consumption in a Sample of British Medical Students,” Medical Education, May 1995;29(3):187–92. (back to text)
51
G. A. Pincomb, W. R. Lovallo, R. B. Passey et al., “Caffeine Enhances the Physiological Response to Occupational Stress in Medical Students,” Health Psychology, 1987;6(2): 101–12. (back to text)
52
R. T. Cox, and R. J. Walker, “An Analysis of the Adenosine Receptors Responsible for Modulation of an Excitatory Acetylcholine Response on an Identified Helix Neuron,” Comparative Biochemistry and Physiology, C: Comparative Pharmacology and Toxicology, 1987;88(1):121–30. (back to text) 53